207 related articles for article (PubMed ID: 14767592)
21. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
22. Epidemiology and outcome of HIV-infected patients admitted to the ICU in the current highly active antiretroviral therapy era.
Vidal-Cortés P; Álvarez-Rocha LA; Fernández-Ugidos P; Pérez-Veloso MA; Suárez-Paul IM; Virgós-Pedreira A; Pértega-Díaz S; Castro-Iglesias ÁC
Med Intensiva (Engl Ed); 2020; 44(5):283-293. PubMed ID: 30971339
[TBL] [Abstract][Full Text] [Related]
23. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
[TBL] [Abstract][Full Text] [Related]
24. Short- and long-term outcomes of HIV-infected patients admitted to the intensive care unit: impact of antiretroviral therapy and immunovirological status.
Morquin D; Le Moing V; Mura T; Makinson A; Klouche K; Jonquet O; Reynes J; Corne P
Ann Intensive Care; 2012 Jul; 2(1):25. PubMed ID: 22762133
[TBL] [Abstract][Full Text] [Related]
25. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.
Lim ST; Karim R; Nathwani BN; Tulpule A; Espina B; Levine AM
J Clin Oncol; 2005 Jul; 23(19):4430-8. PubMed ID: 15883411
[TBL] [Abstract][Full Text] [Related]
26. Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy.
Greenberg JA; Lennox JL; Martin GS
J Crit Care; 2012 Feb; 27(1):51-7. PubMed ID: 22033058
[TBL] [Abstract][Full Text] [Related]
27. Long-term HIV/AIDS survival estimation in the highly active antiretroviral therapy era.
King JT; Justice AC; Roberts MS; Chang CC; Fusco JS;
Med Decis Making; 2003; 23(1):9-20. PubMed ID: 12583451
[TBL] [Abstract][Full Text] [Related]
28. Time to viral load suppression in antiretroviral-naive and -experienced HIV-infected pregnant women on highly active antiretroviral therapy: implications for pregnant women presenting late in gestation.
Aziz N; Sokoloff A; Kornak J; Leva NV; Mendiola ML; Levison J; Feakins C; Shannon M; Cohan D
BJOG; 2013 Nov; 120(12):1534-47. PubMed ID: 23924192
[TBL] [Abstract][Full Text] [Related]
29. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era.
Coquet I; Pavie J; Palmer P; Barbier F; Legriel S; Mayaux J; Molina JM; Schlemmer B; Azoulay E
Crit Care; 2010; 14(3):R107. PubMed ID: 20534139
[TBL] [Abstract][Full Text] [Related]
30. Incidence and prognosis of CMV disease in HIV-infected patients before and after introduction of combination antiretroviral therapy.
Salzberger B; Hartmann P; Hanses F; Uyanik B; Cornely OA; Wöhrmann A; Fätkenheuer G
Infection; 2005 Oct; 33(5-6):345-9. PubMed ID: 16258865
[TBL] [Abstract][Full Text] [Related]
31. A prospective study on the outcome of human immunodeficiency virus-infected patients requiring mechanical ventilation in a high-burden setting.
Balkema CA; Irusen EM; Taljaard JJ; Zeier MD; Koegelenberg CF
QJM; 2016 Jan; 109(1):35-40. PubMed ID: 25979269
[TBL] [Abstract][Full Text] [Related]
32. Survival in HIV-infected patients is associated with hepatitis C virus infection and injecting drug use since the use of highly active antiretroviral therapy in the Lyon observational database.
Voirin N; Trépo C; Miailhes P; Touraine JL; Chidiac C; Peyramond D; Livrozet JM; Ritter J; Chevallier P; Fabry J; Allard R; Vanhems P
J Viral Hepat; 2004 Nov; 11(6):559-62. PubMed ID: 15500557
[TBL] [Abstract][Full Text] [Related]
33. Lung cancer in HIV positive patients: the GICAT experience.
Bearz A; Vaccher E; Martellotta F; Spina M; Talamini R; Lleshi A; Cacopardo B; Nunnari G; Berretta M; Tirelli U;
Eur Rev Med Pharmacol Sci; 2014; 18(4):500-8. PubMed ID: 24610616
[TBL] [Abstract][Full Text] [Related]
34. The impact of HAART on the respiratory complications of HIV infection: longitudinal trends in the MACS and WIHS cohorts.
Gingo MR; Balasubramani GK; Kingsley L; Rinaldo CR; Alden CB; Detels R; Greenblatt RM; Hessol NA; Holman S; Huang L; Kleerup EC; Phair J; Sutton SH; Seaberg EC; Margolick JB; Wisniewski SR; Morris A
PLoS One; 2013; 8(3):e58812. PubMed ID: 23554932
[TBL] [Abstract][Full Text] [Related]
35. Survival of HIV-infected injection drug users (IDUs) in the highly active antiretroviral therapy era, relative to sex- and age-specific survival of HIV-uninfected IDUs.
Muga R; Langohr K; Tor J; Sanvisens A; Serra I; Rey-Joly C; Muñoz A
Clin Infect Dis; 2007 Aug; 45(3):370-6. PubMed ID: 17599317
[TBL] [Abstract][Full Text] [Related]
36. Impact of highly active antiretroviral therapy on the morbidity and mortality in Spanish human immunodeficiency virus-infected children.
Sánchez JM; Ramos Amador JT; Fernández de Miguel S; González Tomée MI; Rojo Conejo P; Ferrnado Vivas P; Clemente Vivas J; Ruiz Contreras J; Nogales Espert A
Pediatr Infect Dis J; 2003 Oct; 22(10):863-7. PubMed ID: 14551485
[TBL] [Abstract][Full Text] [Related]
37. Improved survival with highly active antiretroviral therapy in HIV-infected patients with severe Pneumocystis carinii pneumonia.
Morris A; Wachter RM; Luce J; Turner J; Huang L
AIDS; 2003 Jan; 17(1):73-80. PubMed ID: 12478071
[TBL] [Abstract][Full Text] [Related]
38. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.
Lim ST; Karim R; Tulpule A; Nathwani BN; Levine AM
J Clin Oncol; 2005 Nov; 23(33):8477-82. PubMed ID: 16230675
[TBL] [Abstract][Full Text] [Related]
39. Changes in the pattern of respiratory diseases necessitating hospitalization of HIV-infected patients since the advent of highly active antiretroviral therapy.
Dufour V; Cadranel J; Wislez M; Lavole A; Bergot E; Parrot A; Rufat P; Mayaud C
Lung; 2004; 182(6):331-41. PubMed ID: 15765925
[TBL] [Abstract][Full Text] [Related]
40. Association between Highly Active Antiretroviral Therapy and Type of Infectious Respiratory Disease and All-Cause In-Hospital Mortality in Patients with HIV/AIDS: A Case Series.
Báez-Saldaña R; Villafuerte-García A; Cruz-Hervert P; Delgado-Sánchez G; Ferreyra-Reyes L; Ferreira-Guerrero E; Mongua-Rodríguez N; Montero-Campos R; Melchor-Romero A; García-García L
PLoS One; 2015; 10(9):e0138115. PubMed ID: 26379281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
